Back to Search
LORI FANTRY, MD, MPH
MD, MPH
Infectious Disease Physician
NPI: 1821046277IndividualAccepts Medicare
Education
OTHER
Class of 1985
Research & Publications (16)
Successful treatment with atazanavir and lopinavir/ritonavir combination therapy in protease inhibitor-susceptible and protease inhibitor-resistant HIV-infected patients.
PMID 17134349·AIDS Patient Care STDS·2006
8-other
Age of menopause and menopausal symptoms in HIV-infected women.
PMID 16283830·AIDS Patient Care STDS·2005
8-other
Gastrointestinal infections in the immunocompromised host.
PMID 15687883·Curr Opin Gastroenterol·2005
6-review
Impaired oxygen on-kinetics in persons with human immunodeficiency virus are not due to highly active antiretroviral therapy.
PMID 14669191·Arch Phys Med Rehabil·2003
8-other
Gastrointestinal infections in the immunocompromised host.
PMID 15699891·Curr Opin Gastroenterol·2003
8-other
Decreased peak arteriovenous oxygen difference during treadmill exercise testing in individuals infected with the human immunodeficiency virus.
PMID 14639557·Arch Phys Med Rehabil·2003
8-other
A comparison of Qt and a-vO2 in individuals with HIV taking and not taking HAART.
PMID 12840630·Med Sci Sports Exerc·2003
4-observational
Protease inhibitor-associated diabetes mellitus: a potential cause of morbidity and mortality.
PMID 12626882·J Acquir Immune Defic Syndr·2003
8-other
Mycobacterium avium complex-associated cholecystitis in an HIV-infected woman.
PMID 12055027·AIDS Patient Care STDS·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1501 N CAMPBELL AVE
TUCSON, AZ 85724 - Phone
- (410) 328-9105
Quick Facts
- NPI
- 1821046277
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 16
Are you this provider?
Claim Your Profile